Semaglutide is a GLP-1 receptor agonist used to treat type 2 diabetes and obesity. It lowers blood sugar, reduces appetite, and aids in weight loss. Available as weekly injections (Ozempic, Wegovy) and a daily pill (Rybelsus), it works by mimicking GLP-1 to enhance insulin secretion and slow gastric emptying. Common side effects include nausea and abdominal discomfort.
Semaglutide
$58
Description
Additional information
| Weight |
N/A |
|---|---|
| mg |
2mg , 5mg , 10mg |
Related products
